Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: PHARMARON(03759) the Revenue is 4.636 B (+26.74%), Beat estimate;the EBIT is 593.07 M (+18.28%), Miss estimate;the EPS is 0.261 (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
4.64B26.74%
4.59B25.60%
+0.04B1.14%
EBITMiss expectations
0.59B18.28%
0.60B19.50%
-0.01B1.22%
EPSMiss expectations
0.2612--
0.2885--
-0.0273--%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf